AI-augmented Antibody Discovery

Creative Biolabs is a global company that focuses on antibody development. With extensive experience and advanced platforms, we can provide a series of AI-augmented antibody discovery services for research, diagnostics, and therapeutics. Now we offer a unique way to find rare antibody clusters by augmenting our screening services with an AI-powered antibody drug discovery platform.
Creative Biolabs combines state-of-the-art artificial intelligence, big data, and phage display techniques to discover rare antibodies and expand antibody diversity. At Creative Biolabs, the growing number of biophysical data for various antibody targets has been integrated into the machine learning (ML) algorithms to predict antibodies that bind to a given antigen target with high affinity. The submitted antibody sequences maximize the antibodies’ therapeutic potential while minimizing safety and manufacturing risks. AI technology can also evaluate and optimize the safety, binding affinity, solution viscosity, solubility, as well as pharmacokinetics of specific antibodies.